Tenaya Therapeutics, Inc. (TNYA)

USD 1.23

(-12.77%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue - - - - -
Cost of Revenue 8.68 Million 8.71 Million 4.02 Million 2.48 Million 1.98 Million
Gross Profit -8.68 Million -8.71 Million -4.02 Million -2.48 Million -1.98 Million
Operating Expenses 131.19 Million 125.62 Million 72.8 Million 38.91 Million 27.71 Million
Selling, General and Administrative Expenses 33.15 Million 31.08 Million 18.41 Million 7.81 Million 4.56 Million
Research and Development Expenses 98.03 Million 94.53 Million 54.39 Million 31.09 Million 23.14 Million
Other Expenses - 2000.00 -23 Thousand 430 Thousand 1.02 Million
Cost and Expenses 131.19 Million 125.62 Million 72.8 Million 38.91 Million 27.71 Million
Operating Income -131.19 Million -125.62 Million -72.8 Million -38.91 Million -27.71 Million
Interest Expense - - - - -
Income Tax Expense - -1956.00 -3.06 Million -87 Thousand -453 Thousand
Earnings before Tax -124.08 Million -123.66 Million -72.72 Million -38.39 Million -26.23 Million
Net Income -124.08 Million -123.66 Million -69.65 Million -38.3 Million -25.77 Million
Earnings Per Share Basic -1.68 -2.76 -1.69 -0.93 -0.63
Earnings Per Share Diluted -1.68 -2.76 -1.69 -0.93 -0.63
Weighted Average Shares Outstanding 73.78 Million 44.82 Million 41.29 Million 41.12 Million 41.12 Million
Weighted Average Shares Outstanding (Diluted) 73.78 Million 44.82 Million 41.29 Million 41.12 Million 41.12 Million
Gross Margin - - - - -
EBIT Margin - - - - -
Profit Margin - - - - -
EBITDA -122.5 Million -114.95 Million -68.69 Million -36.42 Million -25.72 Million
Earnings Before Tax Margin - - - - -

Income Statement Charts